A Risk-Based Approach to Immunogenicity Concerns of Therapeutic Protein Products.
Autor: | Rosenberg, Amy S.1 amy.rosenberg@fda.gov, Worobec, Alexandra2 alexandra.worobec@fda.go |
---|---|
Zdroj: | BioPharm International. Nov2004, Vol. 17 Issue 11, p22-26. 4p. |
Databáze: | Business Source Ultimate |
Externí odkaz: |